PARIMA: programs, progress and news

Analyst view

Gourmey founded 2019; raised €48M Series A in October 2022, largest for cultivated meat at the time.
Merged with Vital Meat in October 2025 to form PARIMA, combining duck and chicken with 25-year poultry research.
Cultivated duck approved in Singapore (April 2026); seven regulatory filings globally; positioned for premium dining.

As reported

Avian Cell Lines

Vital Meat's 25 years of avian cell research from Groupe Grimaud validated for duck and chicken production.

Production Economics

Gourmey platform has verified production costs below €7/kg, demonstrating viable commercial path.

Premium Positioning

Michelin-starred restaurants and high-end culinary use; foie gras and duck validated by leading chefs.

Programs

PARIMA, two programs

Updated 1 Apr 2026

Research · Proto · Pilot · Deploy · Scaling

Open · Active · Partial

Scale production to mass marketsActive research
Current production serves high-end restaurants; achieving broader volumes and costs requires manufacturing scale.
Regulatory approvals across major marketsActive research
Seven active filings pending; staggered approvals while maintaining supply is a coordination challenge.

Cultivated meat · 8

1 round · as reported

Date	Round	Amount	Post-money	Lead
Oct 2022	Series A	$53M	—	Earlybird Venture Capital

1 acquirer · 1 partner

Acquirer
Vital Meat (opens gourmey.com)
Acquired October 2025 to form PARIMA; 25 years of avian cell research expertise.
Partner
Groupe Grimaud (opens gourmey.com)
Foundation for Vital Meat's avian cell research and knowledge base.

Key people